Hefei Bionica Pharmaceutical

Hefei Bionica Pharmaceutical is a specialized pharmaceutical manufacturer based in Hefei, China, focusing on anti-viral therapeutics. The company is a core subsidiary of Anhui Biochem Bio-Pharmaceutical and serves as a major production base for antiretroviral (ARV) drugs. Its product portfolio includes essential treatments for HIV/AIDS and Hepatitis B, such as Lamivudine, Zidovudine, and Efavirenz. Hefei Bionica is recognized for its large-scale GMP manufacturing capabilities and its significant contribution to national public health programs in China. The company also engages in the export of active pharmaceutical ingredients and finished formulations to global markets, including those supported by international health organizations. Its research and development efforts are primarily directed toward optimizing small molecule synthesis and expanding its infectious disease pipeline.